GlassScriptPhysician profile
Bill Walker Haney
NPI 1265525653
$2,489.40
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,081 · 2020: $431 · 2021: $899 · 2022: $78.14.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $307.65 | 2019-2021 | |
| Medtronic, INC. | $287.36 | 2021 | |
| Nevro Corp. | $270.87 | 2019-2021 | |
| Flowonix Medical Incorporated | $256.94 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $251.52 | 2019-2022 | |
| Si-Bone, INC. | $214.98 | 2019-2020 | |
| Medtronic USA, INC. | $198.38 | 2019-2020 | |
| Abbvie INC. | $94.91 | 2021-2022 | |
| Pacira Therapeutics, INC. | $71.57 | 2019 | |
| Tersera Therapeutics LLC | $68.21 | 2019 | |
| Daiichi Sankyo INC. | $67.31 | 2019 | |
| Pfizer INC. | $55.43 | 2019-2021 | |
| Zyla Life Sciences, INC. | $48.52 | 2019-2020 | |
| Abbott Laboratories | $44.55 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $41.40 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $39.97 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $29.72 | 2021 | |
| Bioventus LLC | $26.44 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $25.88 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.59 | 2021 | |
| Assertio Therapeutics, INC. | $17.72 | 2019 | |
| Stimwave Technologies Incorporated | $14.32 | 2021 | |
| Ibsa Pharma INC. | $14.22 | 2020 | |
| Allergan, INC. | $11.72 | 2020 | |
| Amgen INC. | $11.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bill Haney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.